1. 364 A personal neoantigen vaccine NEO-PV-01 in combination with chemotherapy and pembrolizumab induces broad de novo immune responses in first line, non-squamous NSCLC. (10th December 2020) Authors: Awad, Mark; Spigel, David; Garon, Edward; Waqar, Saiama; Lisberg, Aaron; Moles, Melissa; Tepper, Jennifer; Lamb, April; Wanamaker, Amy; Khondker, Zakaria; Srouji, John; Dong, Jesse; Poran, Asaf; Balogh, Kristen; Bushway, Meghan; DeMario, Mark; Srinivasan, Lakshmi; Gaynor, Richard; Govindan, Ramas... Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A222 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Avelumab versus docetaxel in patients with platinum-treated advanced non-small-cell lung cancer (JAVELIN Lung 200): an open-label, randomised, phase 3 study. Issue 11 (November 2018) Authors: Barlesi, Fabrice; Vansteenkiste, Johan; Spigel, David; Ishii, Hidenobu; Garassino, Marina; de Marinis, Filippo; Özgüroğlu, Mustafa; Szczesna, Aleksandra; Polychronis, Andreas; Uslu, Ruchan; Krzakowski, Maciej; Lee, Jong-Seok; Calabrò, Luana; Arén Frontera, Osvaldo; Ellers-Lenz, Barbara; Bajars, M... Journal: Lancet oncology Issue: Volume 19:Issue 11(2018) Page Start: 1468 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Durable responders in advanced NSCLC with elevated TMB and treated with 1L immune checkpoint inhibitor: a real-world outcomes analysis. Issue 1 (17th January 2023) Authors: Huang, Richard S P; Carbone, David P; Li, Gerald; Schrock, Alexa; Graf, Ryon P; Zhang, Liangliang; Murugesan, Karthikeyan; Ross, Jeffrey S; Tolba, Khaled; Sands, Jacob; Oxnard, Geoffrey R; Spigel, David Journal: Journal for immunotherapy of cancer Issue: Volume 11:Issue 1(2023) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Durvalumab plus platinum–etoposide versus platinum–etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial. Issue 10212 (23rd November 2019) Authors: Paz-Ares, Luis; Dvorkin, Mikhail; Chen, Yuanbin; Reinmuth, Niels; Hotta, Katsuyuki; Trukhin, Dmytro; Statsenko, Galina; Hochmair, Maximilian J; Özgüroğlu, Mustafa; Ji, Jun Ho; Voitko, Oleksandr; Poltoratskiy, Artem; Ponce, Santiago; Verderame, Francesco; Havel, Libor; Bondarenko, Igor; Kazarnowic... Journal: Lancet Issue: Volume 394:Issue 10212(2019) Page Start: 1929 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Durvalumab, with or without tremelimumab, plus platinum–etoposide versus platinum–etoposide alone in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): updated results from a randomised, controlled, open-label, phase 3 trial. Issue 1 (January 2021) Authors: Goldman, Jonathan W; Dvorkin, Mikhail; Chen, Yuanbin; Reinmuth, Niels; Hotta, Katsuyuki; Trukhin, Dmytro; Statsenko, Galina; Hochmair, Maximilian J; Özgüroğlu, Mustafa; Ji, Jun Ho; Garassino, Marina Chiara; Voitko, Oleksandr; Poltoratskiy, Artem; Ponce, Santiago; Verderame, Francesco; Havel, Libo... Journal: Lancet oncology Issue: Volume 22:Issue 1(2021) Page Start: 51 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Effectiveness of bevacizumab exposure beyond disease progression in patients with non–small‐cell lung cancer: analyses of the ARIES observational cohort study†. Issue 5 (8th January 2016) Authors: Leon, Larry; Kosty, Michael; Jahanzeb, Mohammad; Spigel, David; Wozniak, Antoinette J.; Brahmer, Julie; Fish, Susan; Flick, E. Dawn; Hazard, Sebastien J.; Lynch, Thomas J. Journal: Pharmacoepidemiology and drug safety Issue: Volume 25:Issue 5(2016) Page Start: 569 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Efficacy and safety of first-line avelumab in patients with advanced non-small cell lung cancer: results from a phase Ib cohort of the JAVELIN Solid Tumor study. Issue 2 (8th September 2020) Authors: Verschraegen, Claire F; Jerusalem, Guy; McClay, Edward F; Iannotti, Nicholas; Redfern, Charles H; Bennouna, Jaafar; Chen, Franklin L; Kelly, Karen; Mehnert, Janice; Morris, John C; Taylor, Matthew; Spigel, David; Wang, Ding; Grote, Hans Juergen; Zhou, Dongli; Munshi, Neru; Bajars, Marcis; Gulley,... Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Efficacy and safety of first-line avelumab in patients with advanced non-small cell lung cancer: results from a phase Ib cohort of the JAVELIN Solid Tumor study. Issue 2 (8th September 2020) Authors: Verschraegen, Claire F; Jerusalem, Guy; McClay, Edward F; Iannotti, Nicholas; Redfern, Charles H; Bennouna, Jaafar; Chen, Franklin L; Kelly, Karen; Mehnert, Janice; Morris, John C; Taylor, Matthew; Spigel, David; Wang, Ding; Grote, Hans Juergen; Zhou, Dongli; Munshi, Neru; Bajars, Marcis; Gulley,... Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Efficacy and safety of first-line avelumab in patients with advanced non-small cell lung cancer: results from a phase Ib cohort of the JAVELIN Solid Tumor study. Issue 2 (8th September 2020) Authors: Verschraegen, Claire F; Jerusalem, Guy; McClay, Edward F; Iannotti, Nicholas; Redfern, Charles H; Bennouna, Jaafar; Chen, Franklin L; Kelly, Karen; Mehnert, Janice; Morris, John C; Taylor, Matthew; Spigel, David; Wang, Ding; Grote, Hans Juergen; Zhou, Dongli; Munshi, Neru; Bajars, Marcis; Gulley,... Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Efficacy and safety of first-line avelumab in patients with advanced non-small cell lung cancer: results from a phase Ib cohort of the JAVELIN Solid Tumor study. Issue 2 (8th September 2020) Authors: Verschraegen, Claire F; Jerusalem, Guy; McClay, Edward F; Iannotti, Nicholas; Redfern, Charles H; Bennouna, Jaafar; Chen, Franklin L; Kelly, Karen; Mehnert, Janice; Morris, John C; Taylor, Matthew; Spigel, David; Wang, Ding; Grote, Hans Juergen; Zhou, Dongli; Munshi, Neru; Bajars, Marcis; Gulley,... Journal: Journal for immunotherapy of cancer Issue: Volume 8:Issue 2(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗